It has become increasingly difficult to assist an individual to maintain long term recovery from substance abuse. Irrespective of which treatment centre the individual has been to, none guarantees a successful recovery. This is frustrating to individuals, their families and also service providers. The reason for this trend is not absolutely clear. Many treatment centres are rigid in use of their programs and depend on aftercare to improve ...
Dana Beal – Nerve Growth Factor GDNF Elucidates Ibogaine’s Persistence & Immune Modulatory Effects
Ibogaine shares receptor effects with both Salvia divinorum (κ-opiate down-regulation of tolerance via beta-arrestin) and with ketamine (NMDA antagonism, curbing narcotic withdrawal and super-sensitization to stimulants). Additionally, ibogaine induces the nerve growth factor GDNF (Glia-Derived Neurotrophic Factor), re-sprouting chronically desensitised dopamine receptors and replacing the neural deficit experienced as craving. Moreover, the 10-fold GDNF spike engendered by ibogaine back-signals to cell nuclei to make more GDNF, setting ...
Ibogaine influence on gene expression – Roman Paskulin
Tabernanthe iboga with its alkaloid ibogaine is recognized in the West as a remedy against diverse addictions, while traditionally it is used as inductor of maturation. Its uniqueness lays in the multiple actions – it triggers psychedelic insights, facilitates metabolic adaptations and sets new ...
Panel: Insights from Contemporary Ibogaine Addiction Research w/ Noller & Brown
Learn more and donate: http://www.maps.org/
PANEL:
Geoff Noller, PhD, and Thomas Kingsley Brown, PhD
moderated by Clare Wilkins
Insights from Contemporary
Ibogaine Research for Addiction
2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.
source
Ignacio Carrera: Ibogaine & Neurotrophic Factors: GDNF, BDNF, and NGF Releasing Properties
Learn more and donate: http://www.maps.org/
Ignacio Carrera, PhD
Ibogaine and Neurotrophic Factors: GDNF, BDNF,
and NGF Releasing Properties of Ibogaine and Activity
of Novel Ibogaine Analogues
2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.
source